Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.76 |
| ▸ | HINT1 | P49773 | 4/20 | 0.68 |
| ▸ | NT5E | P21589 | 2/20 | 0.68 |
| ▸ | PNP | P00491 | 1/20 | 0.65 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.65 |
| ▸ | GSK3A | P49840 | 2/20 | 0.64 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.64 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.64 |
| ▸ | TGM2 | P21980 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.62 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.62 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Guanosine SCHEMBL34912 | 1.00 | HPGD (0.76) | HPGDHINT1NT5EPNPPAX8 | |
| Guanosine SCHEMBL8593215 | 1.00 | HPGD (0.76) | HPGDHINT1NT5EPNPPAX8 | |
| Guanosine SCHEMBL413586 | 1.00 | HPGD (0.76) | HPGDHINT1NT5EPNPPAX8 | |
| Guanosine SCHEMBL24049416 | 1.00 | HPGD (0.76) | HPGDHINT1NT5EPNPPAX8 | |
| Guanosine SCHEMBL11986902 | 1.00 | HPGD (0.76) | HPGDHINT1NT5EPNPPAX8 | |
| Guanosine SCHEMBL24049608 | 1.00 | HPGD (0.76) | HPGDHINT1NT5EPNPPAX8 | |
| Guanosine SCHEMBL24049417 | 1.00 | HPGD (0.76) | HPGDHINT1NT5EPNPPAX8 | |
| Guanosine SCHEMBL24049467 | 1.00 | HPGD (0.76) | HPGDHINT1NT5EPNPPAX8 | |
| Guanosine SCHEMBL20750695 | 1.00 | HPGD (0.76) | HPGDHINT1NT5EPNPPAX8 | |
| Guanosine SCHEMBL16800938 | 1.00 | HPGD (0.76) | HPGDHINT1NT5EPNPPAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106047872-A | DNA aptamer sequences for recognizing bentazone and derivatives thereof | 清华大学 | 2016-10-26 | — | — | CN | claimed |
| US-20130183765-A1 | Ultraviolet and High-Performance Liquid Chromatography Methods for the Evaluation of Sunscreen Efficacy | Sena Research Incorporated (US) | 2013-07-18 | — | — | US | claimed |
| EP-3795574-A1 | SYNTHESIS AND USAGE OF 1,2-DIAMINODIAMANTANE PLATINUM(II) COMPLEXES | Justus-Liebig-Universität Gießen (DE) | 2021-03-24 | — | — | EP | disclosed |
| CN-110292163-A | A kind of constant temperature refined honey method | 浙江中医药大学 | 2019-10-01 | — | — | CN | disclosed |
| CN-110184209-A | One plant of Lactobacillus rhamnosus that can reduce blood uric acid | 杭州娃哈哈科技有限公司 | 2019-08-30 | — | — | CN | disclosed |
| US-20190214145-A1 | Method and systems for creating and screening patient metabolite profile to diagnose current medical condition, diagnose current treatment state and recommend new treatment regimen | KUREK ITZHAK (US) | 2019-07-11 | — | — | US | disclosed |
| US-20190003966-A1 | Ultraviolet and High-Performance Liquid Chromatography Methods for the Evaluation of Sunscreen Efficacy | SENA RESEARCH, INCORPORATED (US) | 2019-01-03 | — | — | US | disclosed |
| US-10073033-B2 | Ultraviolet and high-performance liquid chromatography methods for the evaluation of sunscreen efficacy | SENA RESEARCH, INC. (US) | 2018-09-11 | — | — | US | disclosed |
| CN-106635799-A | Screening method of guanosine production bacterial strains | 广东肇庆星湖生物科技股份有限公司 | 2017-05-10 | — | — | CN | disclosed |
| CN-102924551-B | A kind of method extracting guanosine from fermented liquid | TONGLIAO MEIHUA BIOTECHNOLOGY CO., LTD. (CN) | 2016-02-24 | — | — | CN | disclosed |
| CN-101974432-B | High-throughput screening method of guanosine production strains | STAR LAKE BIOSCIENCE CO INC ZHAOQING GUANGDONG | 2015-06-17 | — | — | CN | disclosed |
| CN-101633781-A | Emulsion composition, method for softening fiber structure and fiber containing base material | DOWCORNING SHANGHAI CO LTD | 2010-01-27 | — | — | CN | disclosed |
| CN-101492484-A | Synthetic circulation production process for guanine nucleoside | HUNAN SECO BIOTECHNOLOGY CO LT (CN) | 2009-07-29 | — | — | CN | disclosed |
| CN-101487036-A | Production method of guanine nucleosides | HUNAN SECO CO LTD (CN) | 2009-07-22 | — | — | CN | disclosed |
| CN-1910192-A | Metal complexes having vitamin B12 as a ligand | UNIV ZUERICH (CH) | 2007-02-07 | — | — | CN | disclosed |
| CN-1864697-A | Application of non-adenine in preparation of drug for promoting wound healing | WEIHAI MAPLE LEAF TECHNOLOGY D (CN) | 2006-11-22 | — | — | CN | disclosed |
| EP-1720568-A2 | IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES | Coley Pharmaceutical Group, Inc. (US) | 2006-11-15 | — | — | EP | disclosed |
| US-20050256073-A1 | Immunostimulatory viral RNA oligonucleotides | COLEY PHARMACEUTICAL GROUP, INC. (US) | 2005-11-17 | — | — | US | disclosed |
| WO-2005097993-A2 | IMMUNOSTIMULATORY VIRAL RNA OLIGONUCLEOTIDES | COLEY PHARMACEUTICAL GROUP, INC. (US) | 2005-10-20 | — | — | WO | disclosed |
| US-4816447-A | HERPES VIRUS | MERCK & CO., INC. (US) | 1989-03-28 | — | — | US | disclosed |